Aeterna Zentaris CEO David J. Mazzo And Chief Business Officer Ellen McDonald: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Execs discuss how their BPH treatment will take on products such as Pfizer’s Detrol and GlaxoSmithKline’s Avodart, as well as how their development strategy differs from other biopharmas.